Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01903876 · ClinicalTrials.gov registry record · NA

A Web-based Bystander Education Program

A NA study of Sexual Violence, sponsored by Emory University.

Completed
Registry status
NA
Development phase
743
Enrollment target
1
Study location

NCT01903876: Completed NA study of Sexual Violence, sponsored by Emory University.

NCT01903876 is a NA study of Sexual Violence that has completed, run by Emory University. The registered enrollment target is 743 participants, roughly in line with the 747-participant average among 10 other Sexual Violence trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01903876, a NA study of Sexual Violence, has completed, sponsored by Emory University.

COMPLETED
Registry status
NA
Development phase
743 participants
Enrollment target
1
Study location

Study Summary

This is a study to determine whether a theoretically-driven web-based 3-hour intervention designed for male college students called RealConsent is effective in increasing prosocial intervening behaviors and in preventing sexual violence perpetration. Sexual violence programs for this population have been implemented for decades in the United States, but a program that is web-based and incorporates the bystander education model has never been implemented or tested. In this study, male college students will be recruited online, enrolled and randomly assigned to RealConsent or to a comparison condition. Prior to the intervention, investigators will ask questions about their intervening and sexually coercive behaviors and other theoretical and empirical factors related to the study outcomes. Investigators will survey the young men again at post-intervention, and at 6-months follow-up to determine whether young men in the RealConsent program intervened more often and engaged in less sexual violence compared to young men in the comparison condition. The main hypotheses are: (1) college men in the RealConsent program will report more instances of prosocial intervening; and (2) college men in the RealConsent program will report less sexual violence against women.

Primary Outcome

This scale is the Reactions to Offensive Language and Behavior (ROLB) index that measures whether or not men confronted inappropriate behaviors of other men. We used the 7-item self-behavior subscale plus an additional 8 items, which directly reflected the content of RealConsent. A series of 15 potential intervening situations were presented and participants were asked to indicate whether they had experienced this situation in past 6 months (yes/no), and whether they had intervened (yes/no). The

Conditions Studied

Interventions

  • BEHAVIORAL Bystander & Sexual Violence Prevention
  • BEHAVIORAL General Health Promotion

Study Locations (1)

Georgia

  • Georgia State University - Atlanta

Trial Details

FieldValue
Enrollment Target 743 participants
Start Date 2010-02
Est. Completion 2011-05
Phase NA
Emory University

1,208 total trials

What the finished NCT01903876 record still lists

NCT01903876 is an interventional study that assigns participants to a tested intervention. The registered 743 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 747-participant average among 10 other Sexual Violence trials with a reported enrollment target.

The record links to 1 condition, with Sexual Violence appearing as the primary indexed condition, and to 2 interventions - of which Bystander & Sexual Violence Prevention is the first listed.

NCT01903876 reports a single indexed study location in Georgia.

Frequently Asked Questions

What is clinical trial NCT01903876 about?

NCT01903876 is a clinical study titled "A Web-based Bystander Education Program". This is a study to determine whether a theoretically-driven web-based 3-hour intervention designed for male college students called RealConsent is effective in increasing prosocial intervening behaviors and in preventing sexual violence perpetration. Sexual violence programs for this population have...

What is the current status of trial NCT01903876?

This trial is currently completed. It is a NA study. The enrollment target is 743 participants. The study started on 2010-02. Estimated completion is 2011-05.

What conditions does trial NCT01903876 study?

This clinical trial studies the following conditions: Sexual Violence.

What interventions are being tested in trial NCT01903876?

The interventions under investigation include: Bystander & Sexual Violence Prevention (BEHAVIORAL), General Health Promotion (BEHAVIORAL).

Who is sponsoring clinical trial NCT01903876?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01903876 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sexual Violence

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01903876's enrollment target sits among peer trials

743 3rd of 10 higher than 8 of 10 other Sexual Violence trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Sexual Violence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05619185 · 744 participants · NA

    A SMART Evaluation of an Adaptive Web-based AUD Treatment for Service Members and Their Partners

  • NCT06417814 · 744 participants · Phase 3

    A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer

  • NCT07046351 · 744 participants · NA

    weSIPsmarter: Evaluating a Digital Health Intervention Aimed at Reducing Sugary Drinks Among Rural Head Start Preschoolers and Their Parents

  • NCT07199569 · 744 participants · Phase 2

    Comparability Trial of the MVA-BN Vaccine Manufactured in Different Production Cells

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01903876, the US trial registry maintained by the National Library of Medicine. NCT01903876 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.